rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2008-2-20
|
pubmed:abstractText |
Patients treated with ticlopidine require careful hematologic monitoring. Clopidogrel may have greater tolerability. However, no direct comparison of these two drugs has been reported and evidence of improved safety with clopidogrel is not yet established in the Japanese population. A comparison of both agents was therefore conducted in Japanese stroke patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9786
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2007 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
40-9
|
pubmed:meshHeading |
pubmed-meshheading:18033957-Aged,
pubmed-meshheading:18033957-Cerebral Infarction,
pubmed-meshheading:18033957-Disease-Free Survival,
pubmed-meshheading:18033957-Double-Blind Method,
pubmed-meshheading:18033957-Female,
pubmed-meshheading:18033957-Humans,
pubmed-meshheading:18033957-Japan,
pubmed-meshheading:18033957-Male,
pubmed-meshheading:18033957-Middle Aged,
pubmed-meshheading:18033957-Platelet Aggregation Inhibitors,
pubmed-meshheading:18033957-Ticlopidine,
pubmed-meshheading:18033957-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction.
|
pubmed:affiliation |
Ashikaga Red Cross Hospital, Ashikaga, Japan. y.fukuuchi@ashikaga.jrc.or.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|